论文部分内容阅读
随着 2 0世纪 90年代后期新的抗病毒剂陆续问世 ,已使对慢性乙型肝炎 (CHB)的治疗 ,从效果难于评定的“护肝”治疗到向针对病因治疗转变。现已认为 ,乙型肝炎 (乙肝 )形成慢性化主要是由于乙肝病毒 (HBV)的持续感染。抗病毒治疗可以在相当程度上抑制HBV复制 ,减少传染性 ,改善
With the advent of new antiviral agents in the late 1990s, treatment of chronic hepatitis B (CHB) has been transitioned from “hepatoprotective” treatment that is difficult to assess in effect to therapies that target etiology. It is considered that the chronic form of hepatitis B (HBV) is mainly due to the persistent infection of hepatitis B virus (HBV). Antiviral therapy can to a certain extent inhibit HBV replication, reduce contagious, improve